FMP
NASDAQ
1.27 USD
-0.11 (-8.66%)
Mr. Shaun R. Bagai
Healthcare
Biotechnology
https://renovorx.com
NASDAQ
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
0001574094
US75989R1077
75989R107
4546 El Camino Real
650 284 4433
US
10
Aug 26, 2021
0001574094
NASDAQ
Biotechnology
Healthcare
75989R107
US75989R1077
US
1.27
1.12
74.12k
13.58M
-
0.531-4.6
0.71
-
-
-
-
-1.38
-
https://renovorx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.